Selim M Arcasoy

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes
    Selim M Arcasoy
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    J Heart Lung Transplant 24:1483-8. 2005
  2. ncbi request reprint Medical complications after lung transplantation
    Selim M Arcasoy
    Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Semin Respir Crit Care Med 27:508-20. 2006
  3. ncbi request reprint Medical complications and management of lung transplant recipients
    Selim M Arcasoy
    Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Respir Care Clin N Am 10:505-29. 2004
  4. ncbi request reprint Local and systemic thrombolytic therapy for acute venous thromboembolism
    Selim M Arcasoy
    Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, Lung Transplantation Program, New York Presbyterian Hospital of Columbia, Cornell University, New York, NY 10032, USA
    Clin Chest Med 24:73-91. 2003
  5. ncbi request reprint Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
    Selim M Arcasoy
    Division of Pulmonary, Allergy and Critical Care, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Am J Respir Crit Care Med 167:735-40. 2003
  6. pmc Racial differences in waiting list outcomes in chronic obstructive pulmonary disease
    David J Lederer
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 622 West 168th Street, PH 8, Room 101, New York, NY 10032, USA
    Am J Respir Crit Care Med 177:450-4. 2008
  7. ncbi request reprint Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study
    Muhammet R Celik
    Department of Surgery, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York
    J Heart Lung Transplant 28:697-703. 2009
  8. doi request reprint The modification of diet in renal disease (MDRD) and the prediction of kidney outcomes after lung transplantation
    Nadine Al-Naamani
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    J Heart Lung Transplant 27:1191-7. 2008
  9. pmc Obesity and underweight are associated with an increased risk of death after lung transplantation
    David J Lederer
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Am J Respir Crit Care Med 180:887-95. 2009
  10. pmc Platelet activation in the postoperative period after lung transplantation
    David I Sternberg
    Lung Transplant Program, Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Thorac Cardiovasc Surg 135:679-84. 2008

Collaborators

Detail Information

Publications36

  1. ncbi request reprint Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes
    Selim M Arcasoy
    Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    J Heart Lung Transplant 24:1483-8. 2005
  2. ncbi request reprint Medical complications after lung transplantation
    Selim M Arcasoy
    Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Semin Respir Crit Care Med 27:508-20. 2006
    ..This article reviews the most frequent and important medical complications of lung transplantation, other than rejection and infection, with an emphasis on complications that involve the respiratory tract...
  3. ncbi request reprint Medical complications and management of lung transplant recipients
    Selim M Arcasoy
    Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Respir Care Clin N Am 10:505-29. 2004
    ..Close and parallel attention to pulmonary and nonpulmonary medical complications and management of lung transplant recipients by a multidisciplinary team are the most important ingredients of optimal long-term outcomes...
  4. ncbi request reprint Local and systemic thrombolytic therapy for acute venous thromboembolism
    Selim M Arcasoy
    Pulmonary, Allergy, and Critical Care Division, Columbia University College of Physicians and Surgeons, Lung Transplantation Program, New York Presbyterian Hospital of Columbia, Cornell University, New York, NY 10032, USA
    Clin Chest Med 24:73-91. 2003
    ....
  5. ncbi request reprint Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
    Selim M Arcasoy
    Division of Pulmonary, Allergy and Critical Care, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Am J Respir Crit Care Med 167:735-40. 2003
    ....
  6. pmc Racial differences in waiting list outcomes in chronic obstructive pulmonary disease
    David J Lederer
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 622 West 168th Street, PH 8, Room 101, New York, NY 10032, USA
    Am J Respir Crit Care Med 177:450-4. 2008
    ..Blacks with chronic illness have poorer outcomes than whites in the United States. The health outcomes of minorities with chronic obstructive pulmonary disease (COPD) on the lung transplant waiting list have not been studied...
  7. ncbi request reprint Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study
    Muhammet R Celik
    Department of Surgery, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York
    J Heart Lung Transplant 28:697-703. 2009
    ..The efficacy and safety of different combinations of immunosuppressive regimens after lung transplantation are unknown...
  8. doi request reprint The modification of diet in renal disease (MDRD) and the prediction of kidney outcomes after lung transplantation
    Nadine Al-Naamani
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    J Heart Lung Transplant 27:1191-7. 2008
    ....
  9. pmc Obesity and underweight are associated with an increased risk of death after lung transplantation
    David J Lederer
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Am J Respir Crit Care Med 180:887-95. 2009
    ..Obesity is considered a relative contraindication to lung transplantation, based on studies that have not accounted for key confounders. Little is known about the risk of death for underweight candidates after transplantation...
  10. pmc Platelet activation in the postoperative period after lung transplantation
    David I Sternberg
    Lung Transplant Program, Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Thorac Cardiovasc Surg 135:679-84. 2008
    ..The platelet response to the pulmonary allograft, however, has never been studied. Here we report significant platelet activation immediately after lung transplantation...
  11. ncbi request reprint Outcomes after lung retransplantation in the modern era
    Steven M Kawut
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Am J Respir Crit Care Med 177:114-20. 2008
    ..Characteristics of and survival estimates for recipients of lung retransplantation in the modern era are unknown...
  12. pmc Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis
    David J Lederer
    Department of Medicine, College of Physicians and Surgeons, Joseph L Mailman School of Public Health, Columbia University, New York, New York 10032, USA
    Am J Respir Crit Care Med 174:659-64. 2006
    ..Functional studies may be useful to predict survival in idiopathic pulmonary fibrosis (IPF). Various cutoffs of 6-min-walk distance (6MWD) have been suggested to identify patients at a high risk of death...
  13. ncbi request reprint Risk factors for venous thromboembolism after lung transplantation
    Hilary A Yegen
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Chest 132:547-53. 2007
    ..The risk factors for venous thromboembolism (VTE) following lung transplantation are not well established. We aimed to estimate the incidence of VTE and to identify the risk factors for VTE after lung transplantation...
  14. ncbi request reprint Osteoporosis in diffuse parenchymal lung disease
    Caralee E Caplan-Shaw
    Department of Medicine, Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, New York, NY 10032, USA
    Chest 129:140-6. 2006
    ..We hypothesized that patients with DPLD referred for lung transplantation would have a high prevalence of osteoporosis related to corticosteroid use or reduced pulmonary function and exercise capacity...
  15. pmc Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study
    David J Lederer
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Am J Respir Crit Care Med 184:1055-61. 2011
    ..Obesity has been linked to acute lung injury and is a risk factor for early mortality after lung transplantation...
  16. pmc Immunoglobulin G levels before and after lung transplantation
    Natalie H Yip
    Department of Medicine ad Surgery, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Respir Crit Care Med 173:917-21. 2006
    ..The determinants of immunoglobulin G (IgG) level and the risk of hypogammaglobulinemia (HGG) in patients with severe lung disease before and after lung transplantation are unknown...
  17. ncbi request reprint Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis
    Adel M Assaad
    Department of Pathology, Division of Surgical Pathology, 630 West 168th St, VC14 215, New York, NY 10032, USA
    Chest 131:850-5. 2007
    ..Pulmonary capillary hemangiomatosis (PCH) is a rare cause of pulmonary arterial hypertension with no effective medical therapy and a high risk of mortality. The pathogenesis of PCH is unknown...
  18. ncbi request reprint Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation
    Steven M Kawut
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Respir Med 99:1431-9. 2005
    ..We hypothesized that cardiopulmonary exercise test results and the distance walked in 6min (6MWTD) would be associated with survival in patients with diffuse parenchymal lung disease referred for lung transplantation...
  19. doi request reprint Evaluation of pulmonary function and exercise performance by cardiopulmonary exercise testing before and after lung transplantation
    Matthew N Bartels
    Department of Rehabilitation and Regenerative Medicine, College of Physicians and Surgeons, Columbia University New York, NY, USA
    Chest 140:1604-11. 2011
    ..The objective of this study was to describe and compare posttransplant improvement in lung function and peak exercise parameters in patients with advanced lung disease...
  20. ncbi request reprint Risk factors and outcomes of hypogammaglobulinemia after lung transplantation
    Steven M Kawut
    Department of Medicine, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY 10032, USA
    Transplantation 79:1723-6. 2005
    ..METHODS.: The authors performed a retrospective cohort study of 57 lung transplant recipients at their center. Quantitative total and subclass immunoglobulin (Ig) G levels were obtained from patients...
  21. ncbi request reprint Postlung transplant survival is equivalent regardless of cytomegalovirus match status
    Mark J Russo
    Lung Transplant Program and International Center for Health Outcomes and Innovation Research, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Ann Thorac Surg 84:1129-34; discussion 1134-5. 2007
    ....
  22. pmc Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation
    Rupal J Shah
    Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Transl Res 160:435-42. 2012
    ..Persistent elevations in MCP-1 levels at 24 hours are a biomarker of grade 3 PGD post-transplantation. Monocyte chemotaxis may play a role in the pathogenesis of PGD...
  23. doi request reprint Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis
    Nina M Patel
    Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University, New York, NY 10032, USA
    Eur Respir J 41:1324-30. 2013
    ..Pathways involved in vascular proliferation and aberrant apoptosis, which may contribute to pulmonary vascular remodelling, are activated in IPF patients...
  24. ncbi request reprint Association between pulmonary fibrosis and coronary artery disease
    Jorge R Kizer
    Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
    Arch Intern Med 164:551-6. 2004
    ..Moreover, fibrotic lung diseases exhibit systemic effects and have the potential to affect the vasculature beyond the lung. The existence of a relationship between the two, however, has not been studied...
  25. ncbi request reprint Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome
    David J Lederer
    Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    J Heart Lung Transplant 24:1697-9. 2005
    ..Lung transplantation is a viable therapeutic option in patients with pulmonary fibrosis and only a mild bleeding diathesis associated with HPS...
  26. doi request reprint Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation
    Vivek N Ahya
    Division of Pulmonary, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Heart Lung Transplant 30:175-81. 2011
    ..In this study, we found an increased risk of venous thromboembolism (VTE) in lung transplant recipients treated with a sirolimus (SIR)-based immunosuppressive regimen...
  27. pmc Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study
    Daniela J Lamas
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Respir Crit Care Med 184:842-7. 2011
    ..Idiopathic pulmonary fibrosis is often initially misdiagnosed. Delays in accessing subspecialty care could lead to worse outcomes among those with idiopathic pulmonary fibrosis...
  28. ncbi request reprint Update in surgical therapy for chronic obstructive pulmonary disease
    David J Lederer
    Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, Lung Transplantation Program, PH 14 East, Room 104, New York, NY 10032, USA
    Clin Chest Med 28:639-53, vii. 2007
    ..Recent results from the National Emphysema Treatment Trial, updated International Society for Heart and Lung Transplantation Registry data, and revised guidelines for patient selection for lung transplantation are discussed...
  29. doi request reprint Assessment of kidney function in lung transplant candidates
    Nadine Al-Naamani
    Lung Transplant Program, Columbia University, New York, New York 10032, USA
    J Heart Lung Transplant 27:635-41. 2008
    ..Although creatinine-based formulas that estimate GFR have been derived, none have been validated in patients with severe lung disease...
  30. ncbi request reprint Outcomes of extended donor lung recipients after lung transplantation
    Steven M Kawut
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Transplantation 79:310-6. 2005
    ..Many lung-transplant programs use lungs that do not meet the formal criteria for acceptability; however, the immediate and long-term consequences of this approach remain unclear...
  31. doi request reprint Malignancies following lung transplantation
    Hilary Y Robbins
    Lung Transplantation Program, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY 10032, USA
    Clin Chest Med 32:343-55. 2011
    ..This article addresses the epidemiology, presentation, and treatment of the most common malignancies after lung transplantation, including skin cancer, posttransplant lymphoproliferative disorder, and bronchogenic carcinoma...
  32. ncbi request reprint Pulmonary capillary hemangiomatosis: results of gene expression analysis
    Steven M Kawut
    Department of Medicine, College of Physicians and Surgeons, New York, NY, USA
    Chest 128:575S-5766S. 2005
  33. ncbi request reprint Images in clinical medicine. Pulmonary alveolar proteinosis
    Selim M Arcasoy
    Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    N Engl J Med 347:2133. 2002
  34. ncbi request reprint Surrogate markers and risk factors for chronic lung allograft dysfunction
    Michael E Bowdish
    University of Southern California, Los Angeles, CA, USA
    Am J Transplant 4:1171-8. 2004
    ....
  35. ncbi request reprint Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome
    Wilson Y Szeto
    Department of Surgery, Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
    J Thorac Cardiovasc Surg 124:241-9. 2002
    ....
  36. ncbi request reprint Clinical risk factors for primary graft failure following lung transplantation
    Jason D Christie
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelhia, 19104, USA
    Chest 124:1232-41. 2003
    ..s: Primary graft failure (PGF) is a devastating acute lung injury syndrome following lung transplantation. We sought to identify donor, recipient, and operative risk factors for its development...